Literature DB >> 1419607

Sarcomas in north west England: III. Survival.

A L Hartley1, V Blair, M Harris, J M Birch, S S Banerjee, A J Freemont, J McClure, L J McWilliam.   

Abstract

Survival data on a population-based series of bone, soft tissue and visceral sarcomas diagnosed in the North West of England between 1982-84 and subjected to histopathological peer review are presented. Five-year crude survival for all cases was 34%. Survival in males and females did not differ significantly (P = 0.6, 5-year survival 32% vs 36%) but was markedly worse for patients diagnosed over the median age of 60 years, even when allowance was made for underlying mortality (P = 0.03, 34% vs 44%). Five-year survival rates for the major site groups were: bone 44%; soft tissues of head, neck and trunk 36%; soft tissues of extremities 35%; female genital tract 35%; retroperitoneum 15%; gastro-intestinal tract 13%. Analysis by the major histological types revealed the following survival rates: leiomyosarcoma--female genital tract 25%, gastro-intestinal tract 14%, non-visceral soft tissue 21%; malignant fibrous histiocytoma of soft tissue 29%; liposarcoma 52%; osteosarcoma of bone 46%; and chondrosarcoma of bone 50%.

Entities:  

Mesh:

Year:  1992        PMID: 1419607      PMCID: PMC1977430          DOI: 10.1038/bjc.1992.338

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Prognostication in soft tissue sarcoma. A model with four risk factors.

Authors:  B Rööser; R Attewell; N O Berg; A Rydholm
Journal:  Cancer       Date:  1988-02-15       Impact factor: 6.860

2.  Improvements in survival from childhood cancer: results of a population based survey over 30 years.

Authors:  J M Birch; H B Marsden; P H Jones; D Pearson; V Blair
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-14

3.  Malignant fibrous histiocytoma of soft tissue. A population-based epidemiologic and prognostic study of 137 patients.

Authors:  B Rööser; H Willén; P Gustafson; T A Alvegård; A Rydholm
Journal:  Cancer       Date:  1991-01-15       Impact factor: 6.860

4.  Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials Group.

Authors:  V Bramwell; I Quirt; D Warr; S Verma; V Young; M Knowling; E Eisenhauer
Journal:  J Natl Cancer Inst       Date:  1989-10-04       Impact factor: 13.506

5.  Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma.

Authors:  H D Suit; H J Mankin; W C Wood; K H Proppe
Journal:  Cancer       Date:  1985-06-01       Impact factor: 6.860

Review 6.  Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases.

Authors:  A M Mandard; J F Petiot; J Marnay; J C Mandard; J Chasle; E de Ranieri; P Dupin; P Herlin; J de Ranieri; A Tanguy
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

7.  Prognostic factors for survival in soft tissue sarcoma.

Authors:  J N el-Jabbour; S S Akhtar; G R Kerr; K M McLaren; J F Smyth; A Rodger; R C Leonard
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

8.  Sarcomas in north west England: II. Incidence.

Authors:  A L Hartley; V Blair; M Harris; J M Birch; S S Banerjee; A J Freemont; J McClure; L J McWilliam
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

9.  Sarcomas in north west England: I. Histopathological peer review.

Authors:  M Harris; A L Hartley; V Blair; J M Birch; S S Banerjee; A J Freemont; J McClure; L J McWilliam
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  3 in total

1.  Soft tissue and visceral sarcomas in Irish patients. Interim analysis of data obtained by the Dublin Soft Tissue Tumour Panel.

Authors:  E F Gaffney; P A Dervan; M M McCabe; K Sheahan; E W Kay; M Leader; J Doyle; P A Daly; J J Fennelly; D N Carney
Journal:  Ir J Med Sci       Date:  1994-05       Impact factor: 1.568

2.  Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.

Authors:  C A Stiller; S J Passmore; M E Kroll; P A Brownbill; J C Wallis; A W Craft
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

3.  Multiple primary tumours in a population-based series of patients with histopathologically peer-reviewed sarcomas.

Authors:  A L Hartley; V Blair; M Harris; J M Birch; S S Banerjee; A J Freemont; J McClure; L J McWilliam
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.